CIK 0001420565 · Non-accelerated filer<br>Smaller reporting company
Rein Therapeutics, Inc.
Sign in to watch- Ticker
- RNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 134196017
- Phone
- 7378021989
- Business address
- 12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
- Former names
- Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-29 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10% owner | Sale | −448 | $5.03 | $2K | 1,799,711 |
| 2024-03-05 | WINDSOR JAMES BRIAN President and COO | Option exercise | +2,000 | 7,122 | ||
| 2024-03-05 | WINDSOR JAMES BRIAN President and COO | Option exercise · Series X Non-Voting Convertible Preferred | −2 | 0 | ||
| 2024-02-28 | VON RICKENBACH JOSEF H Director | Grant or award · Stock Option (right to buy) | +2,725 | 2,725 | ||
| 2024-02-28 | Ambros Reinhard J. Director | Grant or award · Stock Option (right to buy) | +2,725 | 2,725 | ||
| 2024-02-28 | Ambros Reinhard J. Director | Grant or award · Stock Option (right to buy) | +2,725 | 2,725 | ||
| 2024-02-28 | VON RICKENBACH JOSEF H Director | Grant or award · Stock Option (right to buy) | +2,725 | 2,725 | ||
| 2023-12-15 | WINDSOR JAMES BRIAN President and COO | Purchase | +225 | $3.37 | $758 | 225 |
| 2023-11-20 | WINDSOR JAMES BRIAN President and COO | Purchase | +5,076 | $1.97 | $10K | 5,122 |
| 2023-10-31 | Fairey William Director | Grant or award · Stock Option (right to buy) | +5,450 | 5,450 | ||
| 2023-10-31 | Musso Alan A Director | Grant or award · Stock Option (right to buy) | +5,450 | 5,450 | ||
| 2022-06-15 | Morrison Jodie Pope Director | Grant or award · Stock Option (right to buy) | +54,500 | 54,500 | ||
| 2022-06-15 | MCKEE WILLIAM Director | Grant or award · Stock Option (right to buy) | +54,500 | 54,500 | ||
| 2022-06-15 | VON RICKENBACH JOSEF H Director | Grant or award · Stock Option (right to buy) | +54,500 | 54,500 | ||
| 2022-06-15 | Sigal Nolan Howard Director | Grant or award · Stock Option (right to buy) | +54,500 | 54,500 | ||
| 2022-06-15 | Ambros Reinhard J. Director | Grant or award · Stock Option (right to buy) | +54,500 | 54,500 | ||
| 2022-06-15 | Bailey Jeffrey Allen Director | Grant or award · Stock Option (right to buy) | +54,500 | 54,500 | ||
| 2022-03-30 | Aivado Manuel See Remarks | Grant or award · Stock Option (right to buy) | +1,133,000 | 1,133,000 | ||
| 2022-03-30 | Vukovic Vojo Chief Medical Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2022-03-30 | Wanstall Rick See Remarks | Grant or award · Stock Option (right to buy) | +393,000 | 393,000 |
Page 5 of 10 · 192 trades